The Abraaj Group announced that it sold its remaining shares in Integrated Diagnostics Holdings or IDH in November 2015, fully exiting its position in the Egyptian diagnostics service provider. Details on how much the sale returned to the private equity investor were not disclosed.
Abraaj has been gradually exiting its position in IDH over the last twelve months. In a partial exit in December 2014, the emerging markets private equity firm sold a 21% stake to Actis in an undisclosed deal. Another more significant stake sale followed in May 2015 when IDH was listed on the London Stock Exchange. According to the Emerging Markets Private Equity Association, Abraaj sold 46 million shares in the offering, returning $203 million to the private equity fund. The IPO was the first-ever primary listing of an Egyptian healthcare business on the London bourse.
To read this article, you must be a paid subscription member. (Current members login here
Reserve your digital subscription today
Join now for $35 per month
Join now for $395 per year
for access to:
- Weekly newsletter with original and curated news, analysis and perspective
- Africa’s private capital deals, fund raises and the investment firms and executives involved
- Portfolio company news that impacts value and stakeholder participation
- Job moves and partnerships between leading market participants
- Exclusive access to Africa Capital Digest’s full content archive
If you’d like more information on exceptional value group subscriptions for your colleagues and teams, please contact Teresa Hall at thall[at]africacapitaldigest.com today.